Stem cell trial for children with Alport syndrome
Treatments studied
Part of Genetic & congenital, Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.
This trial tests whether umbilical cord stem cells can help children with Alport syndrome who have kidney damage. The goal is to see if the treatment can slow down kidney disease and improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 3 and 12 years old.
- They must have a confirmed diagnosis of Alport syndrome.
- They must have protein in their urine, with or without blood in the urine.
- Their kidney function must be at a mild to moderate stage (stage I, II, or III chronic kidney disease).
- They must not have any active infections, allergies, or serious health problems like heart or liver disease.
- They or their family must agree to participate and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called BAY 3401016 to see if it can help adults with Alport syndrome, a genetic condition that affects the kidneys. The drug is given as an infusion or injection and the study will check how well it works and if it is safe.
This trial studies whether an ACE inhibitor (a blood-pressure/kidney-protecting medicine) is safe and effective for adults with Alport syndrome caused by certain COL4A3/COL4A4/COL4A5 gene variants. It aims to see if treatment can help protect kidney function in people who currently have signs like blood or small amounts of protein in the urine.
This study looks at how specific genetic changes (genotypes) relate to kidney problems and urine blood findings in people with Alport syndrome. It may help doctors predict disease course and tailor care, though it may not involve new treatment.
This is a registry that collects information from people with Alport syndrome to better understand the disease and how to delay kidney failure. It may help researchers learn which factors and treatments are most important over time.
This trial tests whether stem cells from donated umbilical cords can help people with acute-on-chronic liver failure, a sudden worsening of chronic liver disease. The goal is to see if this treatment improves liver function and survival.
This study tests whether a single infusion of stem cells from bone marrow is safe for people with chronic kidney disease (CKD). It aims to see if this treatment can help slow kidney function loss.
Hear when a new Alport Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.